Individuals Discontinuing Weight-Loss Jabs Gain Back Pounds Four Times Faster Compared to People Using Diet and Exercise
Fresh analysis suggests that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end conventional lifestyle plans.
Findings released in a prominent health publication shows that while obese people often shed substantial amounts of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Individuals using these drugs need to be informed of the danger of rapid rebound weight gain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery means a return to starting weight in about a year and a half.
Weighing Treatments
The study, which examined 37 of trials involving thousands of patients, compared the effects of the injectable medications with other pills.
Researchers point out that individuals who lose weight through lifestyle changes alone usually have a slower weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Experts believe the mode of action of the drugs accounts for the heightened regain.
GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates hunger.
"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating a significant risk."
A Chronic Issue?
Medical guidelines suggest the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, considering the significant potential of relapse, the therapy should be considered long-term.
This view is supported by pharmaceutical companies, who say that the findings "highlight the chronic character of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
Users who have stopped the jabs describe a sudden return of cravings.
"It felt as if something flipping and you become starving," recalled an individual.
This challenge is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.
Significant Adoption
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is more common among women than males.
- The middle-aged age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a permanent solution and lasting health benefits hinges on integrated lifestyle support.
